CAN-508

N/A

Report date: 2023/05/22 10:15:44
NME

Base Information

Drug NameCAN-508
Drug Alias NameCAN-508
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitors
TargetsCyclin-dependent kinase 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPalacký University Olomouc
China Registration ClassN/A

Develop Information

Active CompaniesPalacký University Olomouc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A